Large genomic databases hold clues linking genetic mutations to future disease risk

September 12, 2017 by Greta Friar, Harvard Medical School
Credit: CC0 Public Domain

Physicians are increasingly using genetic testing to unravel mysterious or rare diseases in patients with baffling symptoms. But untangling mystifying symptoms is only half the battle. The next frontier in genomic analysis is predicting whether a genetic mutation is a harbinger of future disease.

Now scientists from Harvard Medical School have developed a way to increase the predictive accuracy of genetic mutations as forerunners of diseases that may develop down the road. Using large-scale , the team has succeeded in illuminating patterns that can help predict symptoms likely to be caused by poorly understood -causing mutations and can help gauge the likelihood that a patient might develop clinical disease later on.

The said their findings, published Aug. 16 in the journal Cell Systems, could help physicians better monitor future disease risk in patients with obvious symptoms affecting one organ but whose mutation may put them at risk for future disease affecting other organs and systems.

The analysis focused on because these tend to be easier to match to root-cause mutations, the researchers said. To pinpoint mutations common across multiple patients and link them to a specific disease, researchers typically must look at large numbers of sequenced genomes from people with the same diagnoses and then compare them against the genomes of people without such diagnoses. In the case of rare diseases—classified in the United States as those that affect fewer than 200,000 Americans—the pool for sequencing is limited to the genomes of only a handful of people.

On first blush, this may seem like a niche-value proposition, researchers note, but, in truth, the cumulative impact of characterizing the symptoms and future disease risk of many rare conditions could be profound. The National Institutes of Health estimate that as many as 30 million Americans have a rare disease.

"It can be hard to know where to look to diagnose and characterize a rare genetic disease," said study first author Ariel Feiglin, research fellow in at HMS. "Our goal is to give physicians a better starting point for connecting to symptoms in order to plan for their patient's future needs."

In the current study, researchers tested the hypothesis that genetic diseases that affect an organ likely stem from in the most expressed in the tissue that makes up that very organ. For example, if a certain gene produces a protein that is most prevalent in the heart, a mutation to that gene would be the most likely culprit behind a patient's genetic heart disorder. The notion is, by itself not new, the researchers said, but previous studies have yielded conflicting findings. The HMS study results bring some much needed clarity, the researchers said.

In their analysis, the team compared relative expression of the same gene across different tissues as well as expression of different genes relative to each other within the same tissue.

The hypothesis panned out in some tissues but not in others. Mutations in genes highly expressed in the heart, brain, skin and muscle caused disease in these organs more often, the study showed. However, in breast, thyroid, and stomach tissue, the levels of gene expression were not linked to disease risk, a finding that suggests the existence of a more complex interplay in certain tissues.

"Our findings underscore the importance of using big data to tease out important patterns about gene expression—the activity of each gene in each tissue—which can improve our understanding of the meaning of a genetic mutation," said senior author Isaac Kohane, chair of the Department of biomedical informatics at Harvard Medical School.

The researchers said the new findings could give physicians clues about which organs to monitor in patients who come in with symptoms in one organ but turn out to have a mutation linked to multiple organs. For example, the mutation behind a well-known genetic muscle disease was recently found to cause neurodevelopmental disorders in a small percentage of affected individuals. In this case, researchers said, awareness of the tell-tale high level of the relevant gene's expression in the brain could have clued in a physician to check for signs of neurodevelopmental issues in patients with the muscle disease.

"The beauty of these huge databases is that we can leverage existing data to make new discoveries," Feiglin said.

Explore further: Skin disease caused by sperm cell transmission of keratin mutation

More information: Ariel Feiglin et al. Comprehensive Analysis of Tissue-wide Gene Expression and Phenotype Data Reveals Tissues Affected in Rare Genetic Disorders, Cell Systems (2017). DOI: 10.1016/j.cels.2017.06.016

Related Stories

Skin disease caused by sperm cell transmission of keratin mutation

June 16, 2017
Nagoya University research identified a patient with the whole-body skin disease epidermolytic ichthyosis that had been inherited as a germline mutation from her father with the milder epidermolytic nevus. Analysis of genomic ...

Study identifies new gene mutation associated with defective DNA repair and Fanconi anemia

July 10, 2017
Fanconi anemia is a rare genetic disease characterized by hematologic symptoms that include low platelet count and unusually large red blood cells. Mutations in nearly 20 genes have been identified as causative for Fanconi ...

Skin cell model advances study of genetic mutation linked to heart disease, stroke risk

June 27, 2017
Using a new skin cell model, researchers have overcome a barrier that previously prevented the study of living tissue from people at risk for early heart disease and stroke. This research could lead to a new understanding ...

What percentage of ALS is genetic?

June 21, 2017
Up to 90 percent of people with amyotrophic lateral sclerosis (ALS) report that they have no family history of the disease. Now, new research has found approximately 17 percent of such ALS cases may be caused by a gene mutation, ...

Study finds four genes linked to cystic diseases of the liver and kidney

April 6, 2017
Yale researchers are studying kidney and liver diseases to determine which genes are involved in the formation of cysts.

Study finds cause of, and possible cure for, genetic skin disorder

June 1, 2017
Yale scientists have discovered the cause of a disfiguring skin disorder and determined that a commonly used medication can help treat the condition.

Recommended for you

Identifying Crohn's disease risk factors in the Ashkenazi Jewish population

May 25, 2018
It is estimated that one in three individuals of Ashkenazi Jewish (AJ) descent carry mutations that increase their risk for certain genetic diseases. For instance, Crohn's, a highly heritable inflammatory bowel disease, is ...

How do insects survive on a sugary diet?

May 25, 2018
There's a reason parents tell their kids to lay off the sugar: too much isn't good for you.

New chromosome study can lead to personalised counselling of pregnant women

May 25, 2018
Foetuses with a so-called new balanced chromosomal aberration have a higher risk of developing brain disorders such as autism and mental retardation than previously anticipated. The risk is 20 per cent for foetuses with these ...

Regulatory mutations missed in standard genetic screening lead to congenital diseases

May 25, 2018
Researchers have identified a type of genetic aberration to be the cause of certain neurodevelopmental disorders and congenital diseases, such as autism and congenital heart disease, which are undetectable by conventional ...

New findings on autism-related disorder

May 24, 2018
In a study published today in Nature, Marc Bühler and his group at the Friedrich Miescher Institute for Biomedical Research (FMI) have taken a major step forward in elucidating the mechanisms underlying a disorder known ...

Genome study presents new way to track historical demographics of US populations

May 24, 2018
Sharon Browning of the University of Washington and colleagues developed a method to estimate historical effective population size, which is the number of individuals who pass on their genes to the next generation, to reveal ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.